Effect Modification by Acute Coronary Syndrome Prevalence on Non-Invasive Ventilation Efficacy in Acute Cardiogenic Pulmonary Edema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal of Cardiovascular Development and Disease · 2026-03-12 · Meta-analysis
Abstract
Non-invasive ventilation (NIV) reduces mortality in patients with acute cardiogenic pulmonary edema (ACPE). However, the 3CPO trial reported null results. Therefore, we hypothesized that the prevalence of acute coronary syndrome (ACS) would influence the effectiveness of NIV. A systematic literature review was conducted to identify randomized controlled trials (RCTs) comparing NIV and standard oxygen therapy in patients with ACPE from PubMed, CENTRAL, and Embase databases through December 2025. Random-effects meta-analysis and REML meta-regression were utilized, and evidence quality was evaluated using GRADE. (PROSPERO: CRD420251142245). Fourteen RCTs (n = 1967) were included in the analysis. NIV significantly reduced hospital mortality (RR 0.75, 95% CI 0.58-0.96; I2 = 0%) and endotracheal intubation (RR 0.49, 95% CI 0.35-0.68). Meta-regression revealed that study-level ACS prevalence was significantly associated with the magnitude of NIV's mortality effect (β1 = -0.023 per 1% increase in ACS, p = 0.008; R2 = 46.2%). The equilibrium point occurred at an ACS prevalence of 14.1% (95% CI 5.2-23.0%). At 3CPO's ACS prevalence of 27%, the model predicted an RR of 0.75 (95% CI 0.58-0.97). The observed 3CPO RR was 0.97 (95% CI 0.66-1.43); the confidence intervals overlap substantially, and 3CPO was underpowered for mortality as an isolated endpoint. The mortality benefit of NIV appears to be associated with the prevalence of ACS among treated patients, though this ecological finding requires confirmation at the individual-patient level.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
CPAP & NIV · Mortality & survival · Other drugs · Oxygen
Related articles
- Randomised controlled comparison of continuous positive airways pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. (Emerg Med J, 2004)
- Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. (Am J Respir Crit Care Med, 2003)
- Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. (Intensive Care Med, 2004)
- High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. (J Am Coll Cardiol, 2000)
- A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. (Health Technol Assess, 2009)
- Noninvasive ventilation in acute cardiogenic pulmonary edema. (N Engl J Med, 2008)